Conversely, recent evidence strongly indicates that the IGF-1/IGF-1R signaling pathway plays a significant role in promoting tumor metastasis and drug resistance associated with epithelial-to-mesenchymal transition (EMT) (393, 394). This evidence concerns the gene IGF1 and neoplasm.